Skip to main content
Premium Trial:

Request an Annual Quote

Sengenics ImmuKyne Protein Array

Sengenics has launched the ImmuKyne protein array. The array is based on the company's KREX technology for discovering autoantibody biomarker signatures for predicting drug response and severe immune-related adverse events. The new product enables simultaneous screening of more than 300 immunomodulatory autoantigens comprising clinically significant protein classes that may be implicated in acute respiratory distress syndrome (ARDS), such as cytokines, chemokines, and interleukins. All proteins on ImmuKyne are full-length, correctly folded, and functional with both conformational and non-conformational epitopes preserved, which is critical as 90 percent of antibody binding sites are conformational in nature, the company said. The new tool is designed to further COVID-19 research by helping users understand whether autoantibodies play a role in progression to severe disease in COVID-19 patients.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.